Literature DB >> 6125785

Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis.

E J Ross, D C Linch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125785     DOI: 10.1016/s0140-6736(82)92749-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  61 in total

1.  Spontaneous rupture of Achilles tendon: missed presentation of Cushing's syndrome.

Authors:  A Mousa; S Jones; A Toft; P Perros
Journal:  BMJ       Date:  1999-08-28

2.  Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome.

Authors:  T Mengden; P Hubmann; J Müller; P Greminger; W Vetter
Journal:  Clin Investig       Date:  1992-07

3.  The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects.

Authors:  A Scutt; P Bertram; M Bräutigam
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

Review 4.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

Review 5.  Cushing's disease and pregnancy.

Authors:  Nicoletta Polli; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

6.  Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients.

Authors:  M Iacobone; F Mantero; S M Basso; F Lumachi; G Favia
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

7.  Body composition and vertebral fracture risk in female patients treated with glucocorticoid.

Authors:  H Kaji; T Tobimatsu; J Naito; M-F Iu; M Yamauchi; T Sugimoto; K Chihara
Journal:  Osteoporos Int       Date:  2005-12-31       Impact factor: 4.507

8.  Cushing's syndrome: still a potential killing disease.

Authors:  P A Younge; D Shmidt; P G Wiles
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

9.  Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Authors:  P C Souverein; A Berard; T P Van Staa; C Cooper; A C G Egberts; H G M Leufkens; B R Walker
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

10.  Cushing's syndrome due to ectopic adrenocorticotropic hormone production secondary to hepatic carcinoid: diagnosis, treatment, and improved quality of life.

Authors:  Susan G Coe; Winston W Tan; Thomas P Fox
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.